|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,100 KRW | -1.47% |
|
-0.82% | -15.33% |
| 03-14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
JW Pharmaceutical Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 755.49 million compared to KRW 1,388.04 million a year ago. Net income was KRW 15,526.16 million compared to KRW 9,584.03 million a year ago.
Basic earnings per share from continuing operations was KRW 630.3922 compared to KRW 387.2549 a year ago. Basic earnings per share was KRW 630.3922 compared to KRW 387.2549 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.33% | 513M | |
| +29.98% | 682B | |
| +31.74% | 586B | |
| -3.52% | 364B | |
| +18.59% | 327B | |
| +4.07% | 285B | |
| +16.47% | 240B | |
| +9.49% | 209B | |
| -8.67% | 203B | |
| +7.09% | 165B |
JW PHARMACEUTICAL CORPORATION 
